Basic Materials / Specialty ChemicalsNYSE American
$23.35
-0.34 (-1.44%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 25%
FCF escenarios
weak_data · normalized FCF $23.6M · quality 49.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
51/100
C
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$200M
P/E
21.0x
↑EV/EBITDA
7.3x
↓ROE
7.1%
↑Gross Margin
17.4%
↓Debt/Equity
0.21
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2010–2025 · 15 años de histórico normalizado
Revenue CAGR
+6.9%
FCF CAGR
-6.4%
FCF margin
0.7%
FCF / Net income
0.17x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $273.8M · net income $11.2M · FCF $1.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||
| Revenue | $273.8M | $273.8M | $302.4M | $357.7M | $377.4M | $307.5M | $222.4M | $284.3M | $269.5M | $161.7M | $174.9M | $199.1M | $175.2M | $144.1M | $162.4M | $143.4M | $100.3M |
| Net Income | $11.2M | $11.2M | $13.3M | $20.3M | $12.2M | $4.7M | $8.2M | $-15.2M | $-4.8M | $5.5M | $7.4M | $12.1M | $9.6M | $6.9M | $8.2M | $10.5M | $2.4M |
| EBITDA | $27.1M | $27.1M | $31.0M | $39.9M | $28.6M | $22.7M | $22.1M | $-1.2M | $6.3M | $14.2M | $17.8M | — | — | — | — | — | — |
| EPS | 1.29 | 1.29 | 1.51 | 2.31 | 1.44 | 0.55 | 0.98 | -1.94 | -0.62 | 0.70 | 0.97 | 1.58 | 1.28 | 0.92 | 1.11 | 1.44 | 0.34 |
| Gross Margin | 17.4% | 17.4% | 17.6% | 18.0% | 13.9% | 13.4% | 15.5% | 7.6% | 10.1% | 15.2% | 16.0% | 18.2% | 17.2% | 16.4% | 15.9% | 20.8% | 16.3% |
| Operating Margin | 5.2% | 5.2% | 5.5% | 7.4% | 4.8% | 3.6% | 4.7% | -4.1% | -1.2% | 4.9% | 6.6% | — | — | — | — | — | — |
| Net Margin | 4.1% | 4.1% | 4.4% | 5.7% | 3.2% | 1.5% | 3.7% | -5.4% | -1.8% | 3.4% | 4.2% | 6.1% | 5.5% | 4.8% | 5.0% | 7.3% | 2.4% |
| Balance Sheet | |||||||||||||||||
| Debt/Equity | 0.21 | 0.21 | 0.15 | 0.17 | 0.22 | 0.21 | 0.27 | 0.00 | 0.56 | 0.04 | 0.07 | 0.11 | 0.01 | 0.04 | 0.10 | 0.19 | 0.36 |
| Current Ratio | 2.41 | 2.41 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | |||||||||||||||||
| Free Cash Flow | $1.9M | $1.9M | $23.6M | $25.7M | $2.4M | $977000.00 | $24.5M | $9.2M | $-12.3M | $2.7M | $23.2M | $12.9M | $148000.00 | $-2.4M | $6.5M | $2.7M | $5.1M |
| Returns | |||||||||||||||||
| ROE | 7.1% | 7.1% | 9.0% | 14.6% | 10.5% | 4.7% | 8.7% | -18.0% | -4.8% | 5.3% | 7.7% | 13.6% | 12.7% | 10.2% | 14.1% | 21.0% | 6.4% |
| Valuation | |||||||||||||||||
| P/E | 21.04 | 21.04 | 10.42 | 7.43 | 9.03 | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 7.29 | 7.29 | 3.84 | 3.74 | 4.61 | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 1.28 | 1.28 | 0.94 | 1.08 | 0.95 | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | |||||||||||||||||
| Revenue Growth | -9.5% | -9.5% | -15.5% | -5.2% | — | 38.3% | -21.8% | 5.5% | 66.7% | -7.6% | -12.1% | 13.6% | 21.6% | -11.3% | 13.3% | 43.1% | — |
| EPS Growth | -14.6% | -14.6% | -34.6% | 60.4% | — | -43.9% | 150.5% | -212.9% | -188.6% | -27.8% | -38.6% | 23.4% | 39.1% | -17.1% | -22.9% | 323.5% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
17.1%
EPS terminal req.
$2.07
Spread vs growth
-31.7%
5Y implied EPS CAGR
14.2%
EPS terminal req.
$2.51
Spread vs growth
-28.8%
10Y implied EPS CAGR
12.1%
EPS terminal req.
$4.04
Spread vs growth
-26.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+40.1%
Start / end P/E
11.0x → 18.1x
EPS bridge
1.51 → 1.29
Residual
-9.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.